In this Livewire Markets interview, James Rodda discusses the Antipodes Global SMIDS strategy and why now could be a good time look at allocating to global small and mid caps.
Subscribe to receive the latest news and insights from the Antipodes team
IMPORTANT INFORMATION ABOUT THIRD PARTY CONTENT ON THIS WEBSITE:


